COPD

News
AstraZeneca (AZ)

AZ to file COPD combo in China and Japan

AstraZeneca is planning filings of its chronic obstructive pulmonary disease drug Bevespi Aerosphere in China and Japan, based on a new set of positive phase 3 trial results.